Evaluates the latest vitamin D regimens and metabolites as therapies for patients with renal osteodystrophy. Use of calcitriol and alfacalcidol in patients with renal disease; Increasing prevalence of low turnover of bone disease; Need for proper comparison with existing best therapy.